These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30920483)

  • 21. Infection with hepatitis A, B, C, and delta viruses among patients with acute hepatitis in Mongolia.
    Tsatsralt-Od B; Takahashi M; Endo K; Buyankhuu O; Baatarkhuu O; Nishizawa T; Okamoto H
    J Med Virol; 2006 May; 78(5):542-50. PubMed ID: 16555292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serologic markers of hepatitis B virus infection.
    Hoofnagle JH; Schafer DF
    Semin Liver Dis; 1986 Feb; 6(1):1-10. PubMed ID: 3086979
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis delta virus diagnosis.
    Olivero A; Smedile A
    Semin Liver Dis; 2012 Aug; 32(3):220-7. PubMed ID: 22932970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B virus replication in acute hepatitis B, acute hepatitis B virus-hepatitis delta virus coinfection and acute hepatitis delta superinfection.
    Genesca J; Jardi R; Buti M; Vives L; Prat S; Esteban JI; Esteban R; Guardia J
    Hepatology; 1987; 7(3):569-72. PubMed ID: 3570167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis D virus RNA in acute delta infection: serological profile and correlation with other markers of hepatitis D virus infection.
    Buti M; Esteban R; Roggendorf M; Fernandez J; Jardi R; Rashofer R; Allende H; Genesca J; Esteban JI; Guardia J
    Hepatology; 1988; 8(5):1125-9. PubMed ID: 3417234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
    Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
    Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update on HDV: virology, pathogenesis and treatment.
    Alvarado-Mora MV; Locarnini S; Rizzetto M; Pinho JR
    Antivir Ther; 2013; 18(3 Pt B):541-8. PubMed ID: 23792471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Delta hepatitis as a mixed infection].
    Fedorchenko SV; Vovk AD; Vozianova SV
    Vrach Delo; 1990 Mar; (3):5-8. PubMed ID: 2195767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural history of compensated viral B and D cirrhosis.
    Gheorghe L; Iacob S; Simionov I; Vadan R; Gheorghe C; Iacob R; Parvulescu I; Constantinescu I
    Rom J Gastroenterol; 2005 Dec; 14(4):329-35. PubMed ID: 16400347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis of hepatitis delta virus infection.
    Di Bisceglie AM; Negro F
    Hepatology; 1989 Dec; 10(6):1014-6. PubMed ID: 2491738
    [No Abstract]   [Full Text] [Related]  

  • 33. The impact of molecular biology in the diagnosis and management of viral hepatitis.
    Bonino F; Brunetto MR; Smedile A; Chiaberge E
    Ric Clin Lab; 1988; 18(4):261-71. PubMed ID: 3073513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overt and occult hepatitis B virus infection among treatment-naïve HIV-infected patients in Brazil.
    Oliveira MP; Lemes PS; Matos MA; Del-Rios NH; Carneiro MA; Silva ÁM; Lopes CL; Teles SA; Aires RS; Lago BV; Araujo NM; Martins RM
    J Med Virol; 2016 Jul; 88(7):1222-9. PubMed ID: 27061406
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delta agent (type D) hepatitis.
    Bonino F; Smedile A
    Semin Liver Dis; 1986 Feb; 6(1):28-33. PubMed ID: 3520830
    [No Abstract]   [Full Text] [Related]  

  • 36. Does the experience with liver transplantation suggest that hepatitis delta virus is not cytopathic?
    Grendele M; Colledan M; Gridelli B; Rossi G; Fassati LR; Ferla G; Maggi U; Reggiani P; Doglia M; Lunghi G
    Transplant Proc; 1990 Aug; 22(4):1551-3. PubMed ID: 2389397
    [No Abstract]   [Full Text] [Related]  

  • 37. Hepatitis delta in HIV/HBV co-infected patients in Brazil: is it important?
    Mendes-Correa MC; Gomes-Gouvêa MS; Alvarado-Mora MV; Da Silva MH; Lázari C; Cavalcanti NC; Alonso FK; Carpinelli CC; Uip DE; Pinho JR
    Int J Infect Dis; 2011 Dec; 15(12):e828-32. PubMed ID: 21999909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A rare etiology for HBs-Ag negative acute hepatitis B--coinfection by hepatitis B and delta].
    Körner T; Jaspersen D; Roth J; Hammar CH; Bässler R
    Leber Magen Darm; 1994 Sep; 24(5):215-7. PubMed ID: 7968181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis Delta: Prevalence, Natural History, and Treatment Options.
    Hercun J; Koh C; Heller T
    Gastroenterol Clin North Am; 2020 Jun; 49(2):239-252. PubMed ID: 32389361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral hepatitis in HIV infection.
    Cross TJ; Taylor CB; Harrison PM
    N Engl J Med; 2007 Jul; 357(1):90; author reply 91. PubMed ID: 17611215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.